[Therapy of insomnia].
D014151:Anti-Anxiety Agents / Q000627:therapeutic use*; D004341:Drug Evaluation; D006801:Humans; D010919:Placebos; D007319:Sleep Initiation and Maintenance Disorders / Q000188:drug therapy*; D014229:Triazolam / Q000009:adverse effects / Q000627:therapeutic use*
D014151:Anti-Anxiety Agents; D010919:Placebos; D014229:Triazolam
Zur Therapie von Einschlaf-Störungen.